NCT02207972

Brief Summary

The investigators believe that ultrasound guided CSE technique will accurately place the epidural needle in the midline position compared to epidural needle placement via palpation of anatomical landmarks. This will result in positive CSF in the spinal needle, correct placement of the catheter, and adequate symmetrical labor analgesia/anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at below P25 for not_applicable pregnancy

Timeline
Completed

Started May 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 4, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
3 years until next milestone

Results Posted

Study results publicly available

February 13, 2018

Completed
Last Updated

February 13, 2018

Status Verified

February 1, 2018

Enrollment Period

1.8 years

First QC Date

July 31, 2014

Results QC Date

May 10, 2017

Last Update Submit

February 12, 2018

Conditions

Keywords

PregnantlaborEpidural

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Accurate Epidural Placement

    Number of ultrasound guided CSE technique accurately placed epidural needle in the midline position

    2 hours

Secondary Outcomes (2)

  • Number of Participants With Successful First Attempt

    Immediate

  • Number of Participants Without Angle Adjustments in Space Success

    immediate

Study Arms (2)

Use of Ultrasound

ACTIVE COMPARATOR

Woman requests epidural for pain relief Ultrasound guided CSE placed Continuous epidural infusion started Infusion 12 ml/hr of 0.0625% Bupivacaine and Fentanyl 2mcg/ml

Device: Use of Ultrasound

No ultrasound used

ACTIVE COMPARATOR

Palpation of anatomical landmarks Woman requests epidural for pain relief CSE placed using palpation of anatomical landmarks Continuous epidural infusion started Infusion 12 ml/hr of 0.0625% Bupivacaine and Fentanyl 2mcg/ml

Procedure: No ultrasound used

Interventions

The ultrasound imaging of the lumbar spine in different scanning planes facilitates the identification of the landmarks necessary for appropriate epidural space location in pregnant patients. There are two acoustic windows that are effective for lumbar spine sonographic assessment: one seen on the transverse approach, and the other seen on the longitudinal paramedian approach. The ultrasound single-screen method using the transverse approach of the lumbar spine provides reliable information regarding the landmarks required for labor epidurals. The correct interspace and midline position are identified for correct placement of the CSE analgesia.

Use of Ultrasound

Palpation of anatomical landmarks is used for placement of labor analgesia

No ultrasound used

Eligibility Criteria

Age18 Years - 48 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Nulliparious
  • Term (\>37 weeks gestation)
  • Vertex presentation
  • Singleton gestation
  • Ability to provide informed consent
  • Request for analgesia for labor pain
  • Maternal age 18 years or greater

You may not qualify if:

  • Multiparous
  • Preterm (\< 37 weeks gestation)
  • Presentation other than vertex (breech, transverse)
  • Active drug/alcohol dependence
  • Previous spinal surgeries
  • Known spinal deformities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount-Sinai Roosevelt hospital

New York, New York, 10019, United States

Location

Results Point of Contact

Title
Dr Barbara Orlando MD and PI
Organization
Mount Sinai West

Study Officials

  • Migdalia Saloum, MD

    Mount Sinai Roosevelt Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2014

First Posted

August 4, 2014

Study Start

May 1, 2013

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

February 13, 2018

Results First Posted

February 13, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations